These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7658164

  • 1. Immunological and functional properties of in vitro oxidized low density lipoprotein.
    Harduin P, Tailleux A, Lestavel S, Clavey V, Fruchart JC, Fievet C.
    J Lipid Res; 1995 May; 36(5):919-30. PubMed ID: 7658164
    [Abstract] [Full Text] [Related]

  • 2. Resistance to LDL oxidative modifications of an N-terminal apolipoprotein B epitope.
    Gandjini H, Gambert P, Athias A, Lallemant C.
    Atherosclerosis; 1991 Jul; 89(1):83-93. PubMed ID: 1722977
    [Abstract] [Full Text] [Related]

  • 3. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
    Sparrow CP, Parthasarathy S, Steinberg D.
    J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
    Keidar S, Brook GJ, Rosenblat M, Fuhrman B, Dankner G, Aviram M.
    Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074
    [Abstract] [Full Text] [Related]

  • 5. Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins.
    Korotaeva AA, Golovanova NK, Vlasik TN, Yanushevskaya EV, Tsibulsky VP, Yakushkin VV, Tvorogova MG, Morozkin AD, Prokazova NV.
    Biochemistry (Mosc); 1998 Dec; 63(12):1430-7. PubMed ID: 9916162
    [Abstract] [Full Text] [Related]

  • 6. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.
    Viita H, Närvänen O, Ylä-Herttuala S.
    Life Sci; 1999 Dec; 65(8):783-93. PubMed ID: 10466744
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
    Valentinova NV, Gu ZW, Yang M, Yanushevskaya EV, Antonov IV, Guyton JR, Smith CV, Gotto AM, Yang CY.
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
    [Abstract] [Full Text] [Related]

  • 8. Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells.
    Kleinman Y, Krul ES, Burnes M, Aronson W, Pfleger B, Schonfeld G.
    J Lipid Res; 1988 Jun; 29(6):729-43. PubMed ID: 2459282
    [Abstract] [Full Text] [Related]

  • 9. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
    Steinbrecher UP, Lougheed M, Kwan WC, Dirks M.
    J Biol Chem; 1989 Sep 15; 264(26):15216-23. PubMed ID: 2768257
    [Abstract] [Full Text] [Related]

  • 10. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation.
    Negri S, Roma P, Fogliatto R, Uboldi P, Marcovina S, Catapano AL.
    Atherosclerosis; 1993 Jun 15; 101(1):37-41. PubMed ID: 7692863
    [Abstract] [Full Text] [Related]

  • 11. An immunochemical marker of low density lipoprotein oxidation.
    Zawadzki Z, Milne RW, Marcel YL.
    J Lipid Res; 1989 Jun 15; 30(6):885-91. PubMed ID: 2477481
    [Abstract] [Full Text] [Related]

  • 12. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues.
    Oörni K, Pentikäinen MO, Annila A, Kovanen PT.
    J Biol Chem; 1997 Aug 22; 272(34):21303-11. PubMed ID: 9261142
    [Abstract] [Full Text] [Related]

  • 13. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR, Loo G.
    J Pineal Res; 1997 May 22; 22(4):203-9. PubMed ID: 9247205
    [Abstract] [Full Text] [Related]

  • 14. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 15. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M, Leake DS, Rice-Evans CA.
    Biochem J; 1996 Jun 01; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [Abstract] [Full Text] [Related]

  • 16. Use of monoclonal antibodies in studies of lipoprotein structure and function.
    Schonfeld G, Tikkanen MJ, Hahm KS.
    Adv Exp Med Biol; 1985 Jun 01; 183():135-57. PubMed ID: 2412411
    [Abstract] [Full Text] [Related]

  • 17. Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins.
    Edelstein C, Nakajima K, Pfaffinger D, Scanu AM.
    J Lipid Res; 2001 Oct 01; 42(10):1664-70. PubMed ID: 11590223
    [Abstract] [Full Text] [Related]

  • 18. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.
    Marcel YL, Hogue M, Weech PK, Davignon J, Milne RW.
    Arteriosclerosis; 1988 Oct 01; 8(6):832-44. PubMed ID: 2461695
    [Abstract] [Full Text] [Related]

  • 19. Reduced uptake of cholesterol esterase-modified low density lipoprotein by macrophages.
    Aviram M, Keidar S, Rosenblat M, Brook GJ.
    J Biol Chem; 1991 Jun 25; 266(18):11567-74. PubMed ID: 1711036
    [Abstract] [Full Text] [Related]

  • 20. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
    Meyer DF, Mayans MO, Groot PH, Suckling KE, Bruckdorfer KR, Perkins SJ.
    Biochem J; 1995 Sep 01; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.